PacBio: PacBio Q1 Prel. Revenue Down, Says Met Expectations; To Cut Jobs
WASHINGTON (dpa-AFX) - Pacific Biosciences of California, Inc. (PACB) Wednesday reported preliminary revenue of $36.9 million for the first quarter, lower than $38.8 million in the previous year.T...
Read full article »
PacBio is a California-based biotechnology company that designs products such as sequencing systems and application kits for markets including human genomics and gene therapy.
Read more